Title : CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.

Pub. Date : 2020 Feb 21

PMID : 32098220






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, we report the protective effect of CG200745 (CG), a novel histone deacetylase inhibitor, on tubulointerstitial fibrosis in Col4a3-/- mice, a murine model of Alport syndrome. N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide collagen, type IV, alpha 3 Mus musculus
2 Here, we report the protective effect of CG200745 (CG), a novel histone deacetylase inhibitor, on tubulointerstitial fibrosis in Col4a3-/- mice, a murine model of Alport syndrome. N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide collagen, type IV, alpha 3 Mus musculus
3 Morphological analyses revealed CG treatment markedly alleviated kidney fibrosis in Col4a3-/- mice at the age of 7 weeks. N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide collagen, type IV, alpha 3 Mus musculus
4 CG prevented the activation of transforming growth factor beta (TGFbeta) and its downstream SMAD signaling in the kidney of Col4a3-/- mice. N1-(3-(dimethylamino)propyl)-N8-hydroxy-2-((naphthalene-1-loxy)methyl)oct-2-enediamide collagen, type IV, alpha 3 Mus musculus